Glycated albumin is superior to hemoglobin A1c for evaluating the presence and severity of coronary artery disease in type 2 diabetic patients

Cardiology (Switzerland)

Volumn 123, Issue 2, 2012, Pages 84-90

  Shen, Ying ^a   Pu, Li Jin ^b   Lu, Lin ^a,b   Zhang, Qi ^a   Zhang, Rui Yan ^a   Shen, Wei Feng ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiography; Coronary artery disease; Diabetes mellitus; Glycated albumin; Glycated hemoglobin A1c

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SERUM ALBUMIN;

EID: 84866674568     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000342055     Document Type: Article

References (31)

1. Cohen MP, Ziyadeh FN, Chen S: Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. J Lab Clin Med 2006; 147:211-219. (Pubitemid 43668486)
2. Lu L, Peng WH, Wang W, Wang LJ, Chen QJ, Shen WF: Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats. Zheji-ang Univ Sci B 2011; 12:652-659.
3. 1c consistently reflect mean plasma glucose? J Diabetes 2010; 2:92-96.
4. 1c level with the severity of coronary artery disease in patients with diabetes melli-tus. Am J Cardiol 2006; 97:968-969.
5. Ueda H, Mitsusada N, Harimoto K, Miyawa-ki M, Yasuga Y, Hiraoka H: Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus. Cardiology 2010; 116:51-57.
6. Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Lou S, Shen J, Fang DH, Shen WF: Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Dia-betol 2006; 5:27.
7. Lu L, Pu LJ, Zhang Q, Wang LJ, Kang S, Zhang RY, Chen QJ, Wang JG, De Caterina R, Shen WF: Increased glycated albumin and decreased esRAGE levels are related to an-giographic severity and extent of coronary artery disease in patients with type 2 diabetes. Atherosclerosis 2009; 206:540-545.
8. Ai M, Otokozawa S, Schaefer EJ, Asztalos BF, Nakajima K, Shrader P, Kathiresan S, Meigs JB, Williams G, Nathan DM: Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus. Clin Chim Acta 2009; 406:71-74.
9. Okada T, Nakao T, Matsumoto H, Shino T, Nagaoka Y, Tomaru R, Wada T: Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. Intern Med 2007; 46:807-814. (Pubitemid 47261661)
10. Ibrahim AS, El-Remessy AB, Matragoon S, Zhang W, Patel Y, Khan S, Al-Gasyyar MM, El-Shishtawy MM, Liou GI: Retinal microg-lial activation and inflammation induced by Amadori-glycated albumin in a rat model of diabetes. Diabetes 2011; 60:1122-1133.
11. Yang K, Wang XQ, He YS, Lu L, Chen QJ, Liu J, Shen WF: Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells. Cardiovasc Diabe-tol 2010; 9:66.
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Ca re 2003; 26(suppl 1):S5-S20.
13. Service FJ, Rizza RA, Zimmerman BR, Dyck PJ, O'Brien PC, Melton LJ 3rd: The classification of diabetes by clinical and C-peptide criteria. A prospective population-based study. Diabetes Care 1997; 20:198-201. (Pubitemid 27051563)
14. Zhu ZB, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Shen WF: Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT study. Ca rdiology 2009; 112:191-199.
15. Kohzuma T, Koga M: Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus. Mol Diagn Ther 2010; 14:49-51.
16. Cockcroft DW, Gault HM: Prediction of cre-atinine clearance from serum creatinine. Nephron 1976; 16:31-41.
17. Guimarães J, Bastos M, Melo M, Carvalheiro M: Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance. Acta Med Port 2007; 20:145-150. (Pubitemid 47235129)
18. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Bran-cati FL: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362:800-811.
19. Scanlon PJ, Faxon DP, Audet AM: ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiog-raphy and Interventions. J Am Coll Cardiol 1999; 33:1756-1824.
20. 1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int 2010; 30:72-79.
21. Rendell M, Paulsen R, Eastberg S, Stephen PM, Valentine JL, Smith CH, Nierenberg J, Rasbold K, Klenk D, Smith PK: Clinical use and time relationship of changes in affinity measurement of glycosylated albumin and glycosylated hemoglobin. Am J Med Sci 1986; 292:11-14. (Pubitemid 17057421)
22. Koga M, Kasayama S: Clinical impact of gly-cated albumin as another glycemic control marker. Endocr J 2010; 57:751-762.
23. 1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007; 54:139-144. (Pubitemid 46481682)
24. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y, Osaka CKD Expert Research Group: Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007; 18:896-903. (Pubitemid 46434506)
25. Lee BW, Ihm J, Kang JG, Choi MG, Yoo HJ, Ihm SH: Amadori-glycated albumin-induced vascular smooth muscle cell proliferation and expression of inhibitor of apoptosis protein-1 and nerve growth factor-gamma. Biofactors 2007; 31:145-153. (Pubitemid 352789888)
26. Cohen MP, Shea E, Chen S, Shearman CW: Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. J Lab Clin Med 2003; 141:242-249. (Pubitemid 36432924)
27. Hattori Y, Banba N, Gross SS, Kasai K: Gly-cated serum albumin-induced nitric oxide production in vascular smooth muscle cells by nuclear factor kappaB-dependent tran-scriptional activation of inducible nitric oxide synthase. Biochem Biophys Res Commun 1999; 1:128-132. (Pubitemid 29264005)
28. Amore A, Cirina P, Conti G, Cerutti F, Ba-gheri N, Emancipator SN, Coppo R: Amado-ri-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopa-thy. Nephrol Dia l Transplant 2004; 19:53-60. (Pubitemid 38072615)
29. Rodiño-Janeiro BK, González-Peteiro M, Ucieda-Somoza R, González-Juanatey JR, Alvarez E: Glycated albumin, a precursor of advanced glycation end-products, up-regu-lates NADPH oxidase and enhances oxida-tive stress in human endothelial cells: molecular correlate of diabetic vasculopathy. Diabetes Metab Res Rev 2010; 26:550-558.
30. 1c, glycated albumin, fructosamine, 1, 5-anhydroglucitrol, and continuous glucose monitoring. Pediatr Diabetes 2011; 12:690-695.
31. De Caterina R, Zimarino M: Coronary artery remodelling in atherosclerosis: unfortunately unpredictable. Eur Heart J 2006; 27:1761-1763. (Pubitemid 44297373)